Handol is Co-Founder & CEO of Variational AI. Variational AI is a venture-backed generative AI platform-based drug discovery start-up working at the intersection of machine learning and chemistry to create novel and selective cancer drugs. Variational AI’s goal is to deliver better, novel, and safe medicines to patients faster than ever to redefine the unit economics of drug discovery and development.

Handol has 25+ years of technology leadership experience in venture-backed start-ups and public companies in software, mobile, quantum computing, and machine learning in Silicon Valley, Canada, and Asia Pacific. He sits on the boards of the AI Network of BC (AInBC), The Frontier Collective, and the United Way of BC.